Background and Context
The cabinet approved the Bulk Drug Parks Promotion Scheme on 20 March 2020. According to PIB's release of 24 March 2026 (a Rajya Sabha answer on Gujarat), its purpose is to reduce the production cost of bulk drugs through common infrastructure facilities (CIF) by building three bulk drug parks. In financial year 2022-23, three parks were approved in Andhra Pradesh, Gujarat and Himachal Pradesh. Central assistance for the CIF is up to ₹1,000 crore per park or 70 percent of the project cost (90 percent in north-eastern and Himalayan states), whichever is less.
Why in the News
According to PIB's release of 31 July 2026 (a written answer in the Lok Sabha), a grant of ₹1,000 crore is approved for the CIF of the Haroli park in Himachal's Una district. The total project cost is stated as ₹1,923 crore and the CIF cost as ₹1,118.46 crore. As of 30 June 2026, the state had used ₹116.00 crore of the central grant and ₹0.24 crore of the state grant on the CIF.
Key Facts and Figures
| 31 July 2026 (PIB, Lok Sabha answer): grant and cost | Central grant ₹1,000 crore; total project ₹1,923 crore; CIF ₹1,118.46 crore. The approved estimated cost of the CETP (ZLD, 5 MLD) is ₹244.43 crore. The first instalment of ₹225 crore was released to the state agency HPBDPIL on 20 February 2023. The state released ₹35.53 crore. |
|---|---|
| 31 July 2026: progress | Environmental clearance on 25 September 2025. A tender of ₹178.72 crore for phase-1 roads, drains and bridges was awarded and work is under way; a tender of ₹100 crore for site demarcation and levelling was also awarded (phase 1, 800 acres). Tenders for the CETP with ZLD (₹273.6 crore) and steam generation and distribution (₹300 crore) have been issued. |
| 31 July 2026: expectations (government claims) | As per the approved DPR, direct employment of 15,000 to 20,000 and investment of ₹8,000 to 10,000 crore is expected. The hope expressed is that shared facilities will reduce capital and operating costs and help the domestic production of APIs and key starting materials (KSM). |
| 24 March 2026 (PIB, Rajya Sabha answer): Gujarat, the earlier government record | Two instalments of ₹300 crore were received from the centre, of which ₹341.44 crore was used; of the state fund's ₹274.20 crore, ₹206.92 crore. Environmental clearance in February 2024. Most shared civil work was described as complete and utility tenders such as the CETP's have been awarded. |
Checking the figures: what matches and what the source leaves unsaid
What matches (our calculation): adding the CETP with ZLD, ₹273.6 crore, and steam, ₹300 crore, makes ₹573.6 crore, which matches the release's figure "Rs. 573.6"; the release does not write "crore" after it - we took the unit from the components. The ₹1,000 crore grant is about 89.4 percent of the CIF cost of ₹1,118.46 crore. Applying the 90 percent limit, 90 percent of the CIF comes to about ₹1,006.6 crore, that is, the ₹1,000 crore cap appears to apply. This is our calculation.
What shows differently in the source: the CETP's approved estimated cost is ₹244.43 crore, while the CETP tender with ZLD is stated as ₹273.6 crore. The release does not explain this difference, and we do not connect it to Himachal's proposal for additional assistance. What all is included in the tender amount, we have also not read.
Our calculation: utilisation: ₹116.00 crore is about 11.6 percent of the ₹1,000 crore grant and about 51.6 percent of the only stated released instalment of ₹225 crore. The release does not mention further instalments having been released, so it cannot be said that nothing was released later. From Gujarat's March 2026 figures, our calculation: ₹341.44 crore is about 56.9 percent of ₹600 crore and the state fund's ₹206.92/₹274.20 is about 75.5 percent. The dates of the two states' figures differ (30 June 2026 and 24 March 2026), and we have not read Gujarat's total CIF cost, so we do not treat these as comparable.
What is unsaid: the difference between Haroli's total project of ₹1,923 crore and the CIF of ₹1,118.46 crore, that is, about ₹804.54 crore (our subtraction), is not explained in the release. There is a difference between a tender being "issued" and being "awarded"; according to the release, only the tenders of ₹178.72 crore and ₹100 crore have been awarded.
Significance: drug supply, import dependence and environmental compliance
Import dependence: according to PIB, the hope is that shared facilities will increase the domestic production of APIs and KSM and reduce import dependence. This is a hope; this release has no figure of any change in production or imports.
Environment and ZLD: a shared ZLD plant for the drug industry's effluent is the park's central facility, and environmental clearance is stated to have been received on 25 September 2025. The plant's tender has been issued, not awarded, so we say nothing about the state of operations.
Centre-state participation: the state has taken up with the authorities concerned the matters of a gas pipeline, a multi-modal logistics park, a road link from NH-44 and a rail extension from Jaijon (Punjab). There is no proposal for a NIPER extension centre. PIB gave these as information from the state.
Challenges, and what we have not read
The pace of spending and the sources' dates: the first instalment was released in February 2023 and use of ₹116.00 crore is stated as of June 2026. The release does not give its reasons, so we fabricate none. Also, the figures are based on the state government's information.
Needs beyond the shared facilities: the grant is limited to the approved amount, while external links such as roads, rail and gas are described as pending at the state's level. Their timeline is not in the release.
What we have not read: we read both PIB releases in full. The scheme's guidelines, Haroli's DPR, the status of Andhra Pradesh's park, the full text of the Lok Sabha question and figures after 30 June 2026 we have not read, so we make no claim about them.
Way Forward
Treat this as a dated snapshot of the government's status as of 30 June 2026. The employment and investment figures are the DPR's expectations, not outcomes. Gujarat's record is of an earlier date, so keep the dates separate when reading the two together.
Distinction of Concepts
Keep four things separate: (1) approval of a grant, the amount being released and its use; (2) a tender being issued and being awarded; (3) the DPR's expectations and actual outcomes; (4) PIB's figure and our calculation.
Mains Perspective
GS-III: industrial policy, infrastructure, environment; GS-II: centre-state relations and government schemes.
Answer Outline
Introduction: The scheme and the three parks.
Main Body: The limit of the CIF and the grant; Haroli's cost, tenders and use; expectations versus results; external linkages and the environment; limits of the figures.
Conclusion: For shared infrastructure, keep cost, tenders and use of funds separate from facilities in operation and expected benefits; examine the implementation of the Haroli park along with the conditions of external linkages and the environment.
Sources
- PIB, written answer in the Lok Sabha on the bulk drug park in Himachal Pradesh (31 July 2026)
- PIB, written answer in the Rajya Sabha on the progress of bulk drug parks in Gujarat (24 March 2026)
Source: both PIB releases were read in full. The scheme's guidelines, Haroli's DPR, Andhra Pradesh's status, the question's full text and figures after 30 June 2026 were not read.
Remember: according to PIB, a grant of ₹1,000 crore is approved for the Haroli park's CIF and ₹116.00 crore of the central grant was used as of 30 June 2026. The employment and investment figures are the DPR's expectations, and there is a difference between a tender being issued and being awarded.
Download This Article: PDF